Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other neoplasm 1Dermatologic 1

Conditions

Precancerous Conditions 1Melanoma 1Inflammatory Bowel Diseases 1Hepatitis C 1Hematologic Neoplasms 1Granulomatous Disease, Chronic 1Fatigue 1Crohn Disease 1Breast Neoplasms 1Breast Carcinoma In Situ 1

Interventions

tremelimumab 1peginterferon alfa-2b 1Zoledronic Acid 1Zidovudine 1Whole-Body Irradiation 1Valproic Acid 1Tetradecanoylphorbol Acetate 1Sodium Chloride 1Selenium 1Rosuvastatin Calcium 1Rituximab 1Ribavirin 1Peripheral Blood Stem Cell Transplantation 1Oxycodone 1Observation 1Moxifloxacin 1Morphine 1Microarray Analysis 1Methadone 1Laser Therapy 1Interferon alpha-2 1Infliximab 1Gene Expression Profiling 1Gadolinium DTPA 1Fluorodeoxyglucose F18 1Flow Cytometry 1Fentanyl 1Colposcopy 1Ciprofloxacin 1Chromatography, High Pressure Liquid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Precancerous Conditions × Infliximab × Clear all
NCT00897312 2016-04-25

Effect of Biological Therapy on Biomarkers in Patients With Untreated Hepatitis C, Metastatic Melanoma, or Crohn Disease

Vanderbilt-Ingram Cancer Center

Terminated
7 enrolled
DermatologicOther neoplasm

Hepatitis C, Melanoma, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡